Robert W. Wilmott, MD

Chair, Department of Pediatrics

Saint Louis University (SLU)

I have participated in numerous Phase II and III therapeutic trials evaluating new therapies to treat pulmonary disease in cystic fibrosis. Most recently these were studies of denufosol to modulate ion transport in cystic fibrosis.